AbbVie raises 2026 revenue guidance and lifts dividend
FROM THE WIRE · FINANCE.YAHOO.COM
AbbVie (ABBV) just raised its full year 2026 revenue guidance to about US$67.8b and lifted its dividend, after reporting third quarter sales of US$17.4b and net income of US$4.2b. Recent price action has been strong, with AbbVie's share price delivering a 6.1% 1 month gain and a…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishRaised guidance and a higher dividend support a large pharma stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01AbbVie expects 2026 revenue of about US$67.8 billion.
- 02Third-quarter sales were US$17.4 billion.
- 03Net income for the quarter was US$4.2 billion.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets